Webcast ImageWebcast
Q2 2017 Invuity Inc Earnings Conference Call  (Live)
07/25/17 at 5:00 p.m. ET
Q2 2017 Invuity Inc Earnings Conference Call
Tuesday, July 25, 2017 5:00 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013
DateTitle 
11/30/15Invuity Names Greg Lucier Chairman
SAN FRANCISCO, Nov. 30, 2015 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), an advanced medical technology company, announced today that life sciences industry luminary Gregory T. Lucier has been appointed to the role of Chairman of its Board of Directors, effective December 31, 2015. Lucier, who is the chief executive officer of Nuvasive, Inc. (Nasdaq:NUVA), has served on the Invuity board since October 2014. He will take the place of Gregory B. Brown, M.D., who will resign from the Board eff... 
Printer Friendly Version
11/25/15Invuity to Present at Piper Jaffray Healthcare Conference
SAN FRANCISCO, Nov. 25, 2015 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), an advanced medical technology company, today announced that company management is scheduled to present at the Piper Jaffray Healthcare Conference on Wednesday, December 2, 2015 at 9 a.m. ET in New York City. A live, listen-only webcast of the presentation may be accessed by visiting the Events & Presentations section of the Company's website at www.invuity.com under Investors & Media. A replay of the webca... 
Printer Friendly Version
11/17/15Invuity, Inc. (Nasdaq: IVTY) to Ring The Nasdaq Stock Market Closing Bell
What:  Invuity, Inc. (Nasdaq: IVTY), an advanced medical technology company focused on developing Intelligent Photonics™ devices to improve surgeons’ visualization abilities, will visit the Nasdaq MarketSite in Times Square in celebration of its initial public offering earlier this year and the successful launch of its Hidden Scar™ Surgery program for breast cancer surgery, as part of the company's broader women's health initiative. In honor of these milestones, Philip Sawyer... 
Printer Friendly Version
11/11/15Invuity to Present at Upcoming Investor Conferences
SAN FRANCISCO, Nov. 11, 2015 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), an advanced medical technology company, today announced that company management is scheduled to present at the following upcoming investor conferences: The Stifel Healthcare Conference on Wednesday, November 18, 2015 at 1:30 p.m. ET in New York City. The Canaccord Genuity Medical Technology & Diagnostics Forum on Thursday, November 19, 2015 at 11:30 a.m. ET in New York City. Live, listen-only we... 
Printer Friendly Version
11/10/15Invuity Reports 2015 Third Quarter, Nine-Month Financial Results
SAN FRANCISCO, Nov. 10, 2015 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), an advanced medical technology company, today reported financial results for the third quarter and nine-months ended September 30, 2015. Q3 2015 Highlights Revenue grew 50% to $5.6 million compared to revenue of $3.7 million in the 2014 third quarter. Revenue for the first nine months of 2015 increased 70% to $14.8 million from $8.7 million in the prior year period. Approximately 465 hospitals p... 
Printer Friendly Version
10/27/15Invuity Announces 2015 Third Quarter, Nine-Month Results Release and Conference Call Date
SAN FRANCISCO, Oct. 27, 2015 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), an advanced medical technology company, today announced that it will release its 2015 third quarter and nine-month financial results after the market closes on Tuesday, November 10, 2015. In conjunction with the release, the Company will host a conference call with the investment community at 5:00 p.m. Eastern Time on Tuesday, November 10, 2015, to discuss the financial results and other business developments. Inte... 
Printer Friendly Version
10/21/15Invuity Waveguide XT System Earns Spine Technology 2015 Award
“Drop-in” Intracavity Illuminator Wins Best in Cervical Care SAN FRANCISCO, October 21, 2015 - Invuity, Inc. (NASDAQ:IVTY), an advanced medical technology company, today announced that it has been recognized as a winner of Orthopedic This Week’s 2015 Spine Technology Awards in the Cervical Care category. The annual awards, which were presented during the North American Spine Society’s (NASS) Annual Meeting in Chicago in mid-October, recognize exemplary and innovative spine surgery produ... 
Printer Friendly Version
10/16/15Invuity® Announces Eikon™ LT Illuminated Retractor With Tissue Grip For Plastic Surgery
New illuminated retractors in the Eikon LT platform offer improved tissue grip, surgical precision and safety BOSTON, Oct. 16, 2015 /PRNewswire/ -- Invuity, Inc. (NASDAQ:IVTY), an advanced medical technology company, today at the 84th American Society of Plastic Surgeons annual scientific conference, Plastic Surgery: The Meeting, announced the introduction of Eikon™ LT with Tissue Grip to its illuminated retractor platform. Invuity's latest innovation expands clinical applicability and enable... 
Printer Friendly Version
10/05/15Invuity® Announces Launch Of Eikon™ LT Illuminated Retractor System At American College Of Surgeons 2015 Clinical Congress
Non-conductive material, atraumatic blade and ultra-light design provide safety and precision, while reducing surgeon fatigue CHICAGO, Oct. 5, 2015 /PRNewswire/ -- Invuity, Inc. (NASDAQ:IVTY), an advanced medical technology company, today announced the introduction of its Eikon™ LT illuminated retractor system, expanding the company's portfolio of devices that improve intra-cavity illumination and visualization. Eikon LT integrates Invuity's Intelligent Photonics™ technology to enable minimal... 
Printer Friendly Version
10/01/15Invuity® Launches Hidden Scar™ Program For Breast Cancer Surgery At American College Of Surgeons (ACS) Annual Clinical Congress 2015
New initiative enables surgeons to adopt innovative surgical approach that leads to optimal clinical and aesthetic outcomes CHICAGO, Oct. 1, 2015 /PRNewswire/ -- Invuity, Inc. (NASDAQ: IVTY), an advanced medical technology company, announced today the launch of its Hidden ScarTM Surgery program designed to certify surgeons and establish Centers of Excellence at major cancer centers and hospitals across the country. This innovative program will train surgeons on advanced minimally invasive and... 
Printer Friendly Version
09/22/15Invuity® Introduces Eiberg™ Illuminated Retractor System With Integrated Intelligent Photonics™ To Orthopedic Market
Latest innovation further complements company's portfolio of products designed specifically for use in orthopedic surgeries SAN FRANCISCO, Sept. 22, 2015 /PRNewswire/ -- Invuity, Inc. (NASDAQ: IVTY), a leading medical technology company, today announced the introduction of its Eiberg™ Illuminated Retractor System. This latest innovation adds to the company's portfolio of orthopedic products including the Saber Yankauer™ Illuminated Aspiration System and Eivector™ Illuminated Retractor System.... 
Printer Friendly Version
09/14/15Invuity® Reports Positive Clinical And Economic Outcomes Data From Mastectomy Study
New study findings show innovative Intelligent Photonics™ technology helps enable advanced, nipple sparing approach to breast cancer surgery SAN FRANCISCO, Sept. 14, 2015 /PRNewswire/ -- Invuity, Inc. (NASDAQ:IVTY), an advanced medical technology company, today announced the results of a company-sponsored retrospective analysis performed by leading surgeons and validated by an outside healthcare consulting firm. The study demonstrated clear clinical and economic benefits for the use of the co... 
Printer Friendly Version
08/11/15Invuity Reports 2015 Second Quarter, Six-Month Financial Results
Second Quarter Revenue Increased 69 Percent Over Prior Year Period SAN FRANCISCO, Aug. 11, 2015 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a medical technology company, today reported financial results for the second quarter and six-months ended June 30, 2015. Q2 2015 Highlights Revenue grew 69 percent to $4.7 million compared to revenue of $2.8 million in the 2014 second quarter. Revenue would have been $5.0 million, without the impact of a $300,000 adjustment. In... 
Printer Friendly Version
08/10/15Invuity Names James H. Mackaness Chief Financial Officer
SAN FRANCISCO, Aug. 10, 2015 /PRNewswire/ -- Invuity, Inc. (NASDAQ:IVTY), a medical technology company, today announced the appointment of medical device financial and operations executive James H. Mackaness as its Chief Financial Officer, effective August 24th. Mackaness will report directly to President and CEO Philip Sawyer. Mackaness brings more than 20 years of experience as a senior financial executive to Invuity, having worked for both public and private companies in the Bay Area. His ... 
Printer Friendly Version
07/28/15Invuity Announces 2015 Second Quarter, Six-Month Results Release and Conference Call Date
SAN FRANCISCO, July 28, 2015 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading surgical photonics company, today announced that it will release its 2015 second quarter and six-month financial results after the market closes on Tuesday, August 11, 2015. In conjunction with the release, the Company will host a conference call with the investment community at 5:00 p.m. Eastern Time on Tuesday, August 11, 2015, to discuss the financial results and other business developments. Interested... 
Printer Friendly Version
07/21/15The Joint Commission Recognizes Invuity's® Proprietary Photonics Technology For Improved Patient Safety
SAN FRANCISCO, July 21, 2015 /PRNewswire/ -- Invuity, Inc. (Nasdaq: IVTY), a leading surgical photonics company, today reported that The Joint Commission has recognized its proprietary photonics technology as an important innovation in the prevention of unintended retained foreign objects (URFOs) that are left inside patients during surgery. The Joint Commission is the leading hospital accreditation and certification organization in the United States. It recently and independently assessed a... 
Printer Friendly Version
06/18/15Invuity Announces Closing of Initial Public Offering
SAN FRANCISCO, June 18, 2015 /PRNewswire/ -- Invuity, Inc. (Nasdaq: IVTY), a commercial-stage medical technology company pioneering the use of advanced photonics to provide surgeons with improved direct visualization of surgical cavities during minimally invasive and minimal access surgical procedures, today announced the closing of its initial public offering of 4,600,000 shares of its common stock (including 600,000 shares purchased by the underwriters pursuant to an option to purchase additio... 
Printer Friendly Version
06/15/15Invuity Announces Revised Trading Date and Close for Initial Public Offering
SAN FRANCISCO, June 15, 2015 /PRNewswire/ -- Invuity, Inc. today announced a revised initial trading date and expected closing date for its initial public offering of 4,000,000 shares of common stock at a public offering price of $12.00 per share. Shares began trading on the NASDAQ Global Market today under the ticker symbol "IVTY," and the offering is now expected to close by the end of the day on Thursday, June 18, subject to customary closing conditions. Initially, trading was expected to com... 
Printer Friendly Version
06/11/15Invuity Announces Pricing of Initial Public Offering
SAN FRANCISCO, June 11, 2015 /PRNewswire/ -- Invuity, Inc. today announced the pricing of its initial public offering of 4,000,000 shares of common stock at a public offering price of $12.00 per share, before underwriting discounts and commissions. All of the common stock is being offered by Invuity. In addition, Invuity has granted the underwriters a 30-day option to purchase up to an additional 600,000 shares of common stock from the company at the public offering price. The shares are expecte... 
Printer Friendly Version
02/16/15INVUITY® RAISES $20 MILLION FUNDING ROUND
SAN FRANCISCO, February 16, 2015 – Invuity, Inc., a leading surgical photonics company, today announced a $20 million equity financing round led by Wellington Management Company LLP. New board member, Greg Lucier, also participated in the round. Previous investors include HealthCare Royalty Partners, Valence Life Sciences, InterWest Partners and Kleiner Perkins Caufield & Byers. Proceeds will be used to accelerate the company’s growth and to further commercial initiatives across its broad pr... 
Printer Friendly Version